Related Experiment Video
Updated: Apr 21, 2026

15:00
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
3.3K
MObile Technology for Improved Family Planning: update to randomised controlled trial protocol
Chris Smith1, Thoai D Ngo, Phil Edwards
1Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK. christopher.smith@lshtm.ac.uk.
Trials
|November 13, 2014
Summary
This study updates the MObile Technology for Improved Family Planning (Mobi-FPP) trial analysis plan. Extended follow-up will assess long-term contraception use after abortion.
Area of Science:
- Reproductive Health
- Clinical Trials Methodology
- Contraception Research
Background:
- The MObile Technology for Improved Family Planning (Mobi-FPP) study is updating its statistical analysis plan and incorporating long-term follow-up.
- Additional funding and a decision to restrict the primary analysis to participants with available follow-up data prompted these changes.
- All modifications were finalized before the dataset was sealed.
Purpose of the Study:
- To outline modifications to the Mobi-FPP study's statistical analysis plan.
- To detail plans for extended 12-month follow-up to assess long-term intervention effects.
- To ensure comparability with other family planning intervention trials.
Main Methods:
- Primary analysis restricted to participants with 4-month follow-up data on the primary outcome.
- Sensitivity analysis using an extreme-case scenario for participants lost to follow-up.
- Additional 12-month follow-up via telephone self-report for all primary and secondary outcomes, with participant consent obtained at enrollment.
Main Results:
- Primary outcomes at 4 and 12 months include the use of an effective modern contraceptive method.
- Secondary outcomes encompass long-acting contraception use, self-reported pregnancy, and repeat abortion.
- The study will assess the intervention's effect on various contraceptive methods, including long-acting options.
Conclusions:
- Restricting the primary analysis to available follow-up data aligns with standard trial practices and enhances inter-trial comparability.
- The planned 12-month follow-up will provide crucial data on the intervention's long-term effectiveness in increasing contraception uptake and use.

